Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial-Reference-Cited by-同舟云学术

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

Published:2015-04 Issue:9977 Volume:385 Page:1527-1535
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Raungaard Bent,Jensen Lisette Okkels,Tilsted Hans-Henrik,Christiansen Evald Høj,Maeng Michael,Terkelsen Christian Juhl,Krusell Lars Romer,Kaltoft Anne,Kristensen Steen Dalby,Bøtker Hans Erik,Thuesen Leif,Aarøe Jens,Jensen Svend Eggert,Villadsen Anton Boel,Thayssen Per,Veien Karsten Tange,Hansen Knud Nørregaard,Junker Anders,Madsen Morten,Ravkilde Jan,Lassen Jens Flensted

Publisher

Elsevier BV

Subject

General Medicine

Reference41 articles.

1. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization;Morice;N Engl J Med,2002

2. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

3. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

4. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study;Daemen;Lancet,2007

5. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry;Jensen;EuroIntervention,2010

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physicochemical Properties of the Ideal Materials for Cardiac Devices;Application of Biomaterials in the Treatment of Cardiovascular Diseases;2024

2. Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial;The American Journal of Cardiology;2023-12

3. Evolution of Coronary Stent Platforms: A Brief Overview of Currently Used Drug-Eluting Stents;Journal of Clinical Medicine;2023-10-24

4. Biolimus-eluting vs. other limus-eluting stents in NSTE-ACS: A pooled analysis of GLASSY and TWILIGHT;International Journal of Cardiology;2023-07

5. Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries;Journal of Clinical Epidemiology;2023-07